|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 一项关于恩替卡韦联合聚乙二醇干扰素治疗HBeAg阳性慢性乙型肝炎的多中心随机对照研究显示文摘恩替卡韦可以强有力地抑制HBV的复制,但是需要长期治疗。荷兰鹿特丹Erasmus MC大学医学中心的Brouwer WP等人通过一项全球、开放的多中心随机对照试验,研究恩替卡韦联合聚乙二醇干扰素是否可以提高病毒学应答效率。他们初始采用恩替卡韦(0.5 mg/d)单药治疗HBe Ag阳性慢性乙型肝炎(CHB)的代偿性肝病患者,在治疗24周后,将患者按1∶1随机分为2组,恩替卡韦联合聚乙二醇干扰素(180μg/周)治疗组和恩替卡韦单药治疗组,治疗至48周。 | Brouwer WP 王欢 赵旭 | 2015 | 临床肝胆病杂志2015，31，1： | 3 |
| 2 | Adding pegylated interfer- on to entecavir for hepatitis B e antigen-positive chronic hepatitis B : A multicenter randomized trial (ARES study ) 显示文摘 | Brouwer WP Xie Q Sonneveld M J | 2015 | Hepatology2015，61，5： | 1 |
| 3 | 聚乙二醇干扰素联合恩替卡韦治疗HBeAg阳性慢性乙型肝炎患者:一项多中心随机试验(ARES研究)显示文摘【据《Hepatology》2015年5月报道】题:聚乙二醇干扰素联合恩替卡韦治疗HBeA g抗原阳性慢性乙型肝炎患者:一项多中心随机试验(ARES研究)(作者Brouwer WP等)恩替卡韦能有效抑制HBV复制,但需要长期治疗。为了研究聚乙二醇干扰素联合恩替卡韦是否能提高血清病毒学应答率,伊拉兹马斯大学的Brouwer等进行了全球的首次、非盲、多中心、随机试验。纳入研究者为HBeA g阳性的肝功能代偿期的慢性乙型肝炎患者,开始单用恩替卡韦治疗(0.5 mg/d), | 潘煜 李婉玉 Brouwer WP | 2015 | 临床肝胆病杂志2015，31，8： | 1 |
| 4 | Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function显示文摘 | Kleijn SA Brouwer WP Aly MF | | 0，，： | 1 |
| 5 | Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function显示文摘 | Kleijn SA Brouwer WP Aly MF | 2012 | Eur Heart J Cardiovasc 1maging2012，13，10： | 1 |
| 6 | Adding pegylatedinterferon to entecavir for hepatitis B e antigen-positive chronichepatitis B: a multicenter randomized trial (ARES study) 显示文摘 | Brouwer WP Xie Q Sonneveld MJ | 2015 | Hepatology2015，61，5： | 1 |
| 7 | Three-dimensional speckle Wacking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy显示文摘 | Aly MF Brouwer WP Kleijn SA | 2014 | IntJ Cardiovasc Imaging2014，30，3： | 1 |
| 8 | Three-dimensional speckletracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy 显示文摘 | Aly MF Brouwer WP Kleijn SA | 2014 | Int J Cardiovasc Imaging2014，30，3： | 1 |
| 9 | Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype显示文摘 | Sonneveld MJ Brouwer WP Janssen HL | 2013 | Hepatology2013，57，： | 1 |
| 10 | Comparison between three- dimensional speckle tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function显示文摘 | Kleijn SA Brouwer WP Aly MF | 2012 | Eur Heart J Cardiovasc Imaging2012，13，10： | 1 |
| 11 | Comparison between three - dimensional speckle - tracking echocardiography and cardi- ac magnetic resonance imaging for quantification of left ventricular volumes and function 显示文摘 | Kleijn SA Brouwer WP Aly MF | 2012 | Eur Heart J Cardiovasc Imaging2012，13，10： | 1 |
| 12 | Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function显示文摘 | Kleijn SA Brouwer WP Aly MF | | 0，，10： | 1 |
| 13 | In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy显示文摘 | Brouwer WP Baars EN Germans T | 2014 | J Cardiovasc Magn Reson2014，16，： | 1 |
| 14 | In-vivo T1 cardiovas- cular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy 显示文摘 | Brouwer WP Baars EN Germans T | 2014 | J Cardiovasc Magn Reson2014，16，1： | 1 |
| 15 | Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: a multicenter randomized trial (ARES study)显示文摘 | Brouwer WP Xie Q Sonneveld MJ | 2015 | Hepatology2015，61，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员